Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Synta Earns $25M Milestone From GSK For Melanoma Candidate

Oct 14 2008

Related Content

GlaxoSmithKline Finds ‘Synta’ergy With $1 Billion Deal For Oncology Candidate

Oct 10 2007

Synta’s Melanoma Phase III Could Pack More Punch

Mar 21 2008

GSK/Synta Elesclomol Analysis Shows Stronger Benefit In Treatment Naive Patients

May 20 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window